Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry in water. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.
| Market Capitalization | $3.4778 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 0.008 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.02 |
| EBITDA | -2,020.411 |
| Profit Margin | -1.624 |
| Operating Margin TTM | -1.6416 |
| Return on Assets TTM | -0.8021 |
| Return on Equity TTM | -1.7679 |
| Revenue TTM | 1,245.846 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2011-06-30 | ||||
| 2012-06-30 | 110 | 185 | ||
| 2013-06-30 | 90 | 171 | ||
| 2014-06-30 | 90 | 256 | -166.117 | 965.294 |
| 2015-06-30 | 202.29 | 213.565 | -152.182 | 1,997.515 |
| 2016-06-30 | 2,283.095 | 878.86 | 2,283.095 | 3,524.419 |
| 2017-06-30 | 322.182 | 1,264.174 | 322.182 | 4,857.234 |
| 2018-06-30 | 6.467 | 785.931 | 6.467 | 5,133.991 |
| 2019-06-30 | 663.405 | 776.256 | 663.405 | 4,551.751 |
| 2020-06-30 | 0 | 4,205.919 | ||
| 2021-06-30 | 0 | 3,112.718 | ||
| 2022-06-30 | 0 | 3,022.213 | ||
| 2023-06-30 | 3,284.924 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2011-06-30 | 3 | 4 | 20 | 1 | ||
| 2012-06-30 | 43 | 50 | 146 | 1 | ||
| 2013-06-30 | 66 | 72 | 353 | 1 | ||
| 2014-06-30 | 7,450.355 | 7,453.671 | 227.617 | 8,491.055 | ||
| 2015-06-30 | 1,497.539 | 5,627.794 | 146.978 | 4,053.419 | 8,420.555 | |
| 2016-06-30 | 6,387.041 | 13,919.961 | 444.618 | 7,437.669 | 16,941.392 | |
| 2017-06-30 | 8,766.869 | 12,316.577 | 295.438 | 2,093.166 | 16,941.392 | |
| 2018-06-30 | 1,447.732 | 9,812.405 | 1,224.955 | 6,294.339 | 16,941.392 | |
| 2019-06-30 | 1,360.077 | 6,382.326 | 466.759 | 4,050 | 16,941.392 | |
| 2020-06-30 | 2,682.368 | 3,343.628 | 486.963 | 0 | 17,039.59 | |
| 2021-06-30 | 3,432.077 | 4,326.79 | 496.672 | 14.116 | 19,755.634 | |
| 2022-06-30 | 1,120.204 | 1,767.657 | 403.354 | 20.656 | 19,908.471 | |
| 2023-06-30 | 351.184 | 1,419.373 | 494.832 | 0 | 21,368.718 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2011-06-30 | ||||||
| 2012-06-30 | ||||||
| 2013-06-30 | ||||||
| 2014-06-30 | -862.856 | -639.266 | 985.067 | 1,051.082 | ||
| 2015-06-30 | -1,795.228 | -1,924.611 | 446.457 | 1,051.082 | 1,497.539 | |
| 2016-06-30 | -723.934 | -280.366 | 4,889.502 | 1,497.539 | 6,387.041 | 0 |
| 2017-06-30 | -1,705.002 | -2,878.558 | 2,379.828 | 6,387.041 | 8,766.869 | 0 |
| 2018-06-30 | -3,569.016 | -3,315.146 | -7,319.137 | 8,766.869 | 1,447.732 | |
| 2019-06-30 | -1,848.198 | -2,237.655 | -87.655 | 1,447.732 | 1,360.077 | |
| 2020-06-30 | -2,523.369 | -2,724.899 | 1,322.291 | 1,360.077 | 2,682.368 | |
| 2021-06-30 | -1,996.174 | -2,097.477 | 749.709 | 2,682.368 | 3,432.077 | |
| 2022-06-30 | -2,535.613 | -2,510.936 | -2,311.873 | 3,432.077 | 1,120.204 | |
| 2023-06-30 | -2,023.188 | -2,257.9 | -769.02 | 1,120.204 | 351.184 |